Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · November 07, 2022

Effect of a 4-Week Treatment With Liraglutide on Liver Fat and Concomitantly Circulating Glucagon in Individuals With Overweight

International Journal of Obesity (2005)


Additional Info

International Journal of Obesity (2005)
Four weeks treatment with the GLP-1 receptor analogue liraglutide lowers liver fat and concomitantly circulating glucagon in individuals with overweight
Int J Obes (Lond) 2022 Nov 01;46(11)2058-2062, MS Svane, HH Johannesen, AE Hansen, C Martinussen, KN Bojsen-Møller, ML Hansen, CF Deacon, SH Keller, TL Klausen, A Loft, A Kjaer, J Löfgren, S Madsbad, JJ Holst, NJ Wewer Albrechtsen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading